Table of Contents:

1 Report Prologue
2 Market Introduction
2.1 Definition
2.2 Scope of the Study
2.3 List of Assumptions
2.4 Market Structure
3 Research Methodology
3.1 Research Process
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
3.5 Forecast Model
4 Market Dynamics
4.1 Introduction
4.2 Drivers
4.2.1 Growing Prevalence of Diabetes and Chronic Wounds
4.2.2 Rapidly Growing Geriatric Population
4.2.3 Growing Innovations in Advanced Wound Therapy Devices
4.3 Restraint
4.3.1 High Cost of Advanced Wound Therapy Devices
4.4 Opportunity
4.4.1 Growing Reimbursement for Advanced Wound Therapy Devices
5 Market Factor Analysis
5.1 Value Chain Analysis
5.1.1 R&D and Designing
5.1.2 Manufacturing
5.1.3 Distribution & Sales
5.1.4 Post-Sales Review
5.2 Porter's Five Forces Model
5.2.1 Bargaining Power of Suppliers
5.2.2 Bargaining Power of Buyers
5.2.3 Threat of New Entrants
5.2.4 Threat of Substitutes
5.2.5 Intense Rivalry
5.3 Investment Opportunities
5.4 Pricing Analysis
6 Global Advanced Wound Therapy Devices, By Type
6.1 Introduction
6.1.1 Negative Pressure Wound Therapy Systems
6.1.2 Pressure Relief Devices
6.1.3 Hyperbaric Oxygen Equipment
6.1.4 Electrical Stimulation Devices
6.1.5 Others
7 Global Advanced Wound Therapy Devices Market, By End User
7.1 Introduction
7.1.1 Hospitals and Clinics
7.1.2 Home Care Settings
7.1.3 Others
8 Global Advanced Wound Therapy Devices Market, By Region
8.1 Introduction
8.2 Americas
8.2.1 North America
8.2.1.1 US
8.2.1.2 Canada
8.2.2 South America
8.3 Europe
8.3.1 Western Europe
8.3.1.1 Germany
8.3.1.2 France
8.3.1.3 UK
8.3.1.4 Italy
8.3.1.5 Spain
8.3.1.6 Rest of Western Europe
8.3.2 Eastern Europe
8.4 Asia-Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 Republic of Korea
8.4.6 Rest of Asia-Pacific
8.5 Middle East & Africa
8.5.1 Middle East
8.5.2 Africa
9 Competitive Landscape
9.1 Company Market Share Analysis
9.1.1 Introduction
10 Company Profiles
10.1 Smith & Nephew
10.1.1 Company Overview
10.1.2 Financial Overview
10.1.3 Products/Services Offered
10.1.4 SWOT Analysis
10.1.5 Key Development
10.1.6 Key Strategies
10.2 Molnlycke Health Care AB
10.2.1 Company Overview
10.2.2 Financial Overview
10.2.3 Products/Services Offered
10.2.4 SWOT Analysis
10.2.5 Key Developments
10.2.6 Key strategy
10.3 B. Braun Melsungen AG
10.3.1 Company Overview
10.3.2 Financial Overview
10.3.3 Products/Services Offered
10.3.4 SWOT Analysis
10.3.5 Key Developments
10.3.6 Key strategy
10.4 ConvaTec Inc.
10.4.1 Company Overview
10.4.2 Financial Overview
10.4.3 Products/Services Offered
10.4.4 SWOT Analysis
10.4.5 Key Developments
10.4.6 Key Strategy
10.5 Cardinal Health
10.5.1 Company Overview
10.5.2 Financial Overview
10.5.3 Products/Services Offered
10.5.4 SWOT Analysis
10.5.5 Key Developments
10.5.6 Key Strategy
10.6 KCI Licensing, Inc.
10.6.1 Company Overview
10.6.2 Financial Overview
10.6.3 Products/Services Offered
10.6.4 SWOT Analysis
10.6.5 Key Development
10.6.6 Key Strategy
10.7 Lohmann & Rauscher GmbH & Co. KG
10.7.1 Company Overview
10.7.2 Financial Overview
10.7.3 Products/Services Offered
10.7.4 SWOT Analysis
10.7.5 Key Development
10.7.6 Key Strategy
10.8 DeRoyal Industries, Inc.
10.8.1 Company Overview
10.8.2 Financial Overview
10.8.3 Products/Services Offered
10.8.4 SWOT Analysis
10.8.5 Key Development
10.8.6 Key Strategy
10.9 Medela AG
10.9.1 Company Overview
10.9.2 Financial Overview
10.9.3 Products/Services Offered
10.9.4 SWOT Analysis
10.9.5 Key Development
10.9.6 Key Strategy
10.1 Perry Baromedical
10.10.1 Company Overview
10.10.2 Financial Overview
10.10.3 Products/Services Offered
10.10.4 SWOT Analysis
10.10.5 Key Development
10.10.6 Key Strategy
10.11 Triage Meditech Pvt. Ltd.
10.11.1 Company Overview
10.11.2 Financial Overview
10.11.3 Products/Services Offered
10.11.4 SWOT Analysis
10.11.5 Key Development
10.11.6 Key Strategy
10.12 Sechrist
10.12.1 Company Overview
10.12.2 Financial Overview
10.12.3 Products/Services Offered
10.12.4 SWOT Analysis
10.12.5 Key Development
10.12.6 Key Strategy
11 Appendix
11.1 Discussion Blue Print